My Companies
Notification
Account
Received ANVISA Brazil GMP certificate (CBPF) for Unit II Chincholi for API Levanlodipine Besylate Hemipentahydrate under Resolution RE 4,179 dated 22 Oct 2026, valid till 26 Oct 2028. Context: clears pending Brazil approval for regulated-market conversion.
No events have occurred recently